Annual report
7716.TEDINET S100T5R7
Period2023-01-01 → 2023-12-31
Filed2024-03-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥59.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥48.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥33.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥35.4bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥14.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥15.4bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥17.2bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.6bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.8bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥28.8bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥17.3bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.5bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.1bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥12.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥140.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥102.6bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥94.5bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥82.5bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥77.5bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥27.5bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥11.6bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥113.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥91.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥82.9bn | at 2021-12-31d | Cons. | Net assets |
| Net assets / equity | ¥76.3bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥72.5bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥35.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥26.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥31.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥24.7bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥8.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9.2bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥19.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.3bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥3.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.7bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.8bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥268.04 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.48 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.49 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.97 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥267.29 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥145.11 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥74.34 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.8 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,323.17 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,065.57 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥959.59 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥877.95 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥834.32 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 80.2% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.2% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 22.4% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,049 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 1,478 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 1,239 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 1,184 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 1,159 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥36.7bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥34.4bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥32.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥25.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥26.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥10.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥10.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥15.7bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.8bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.6bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥15.1bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥12.1bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥11.8bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥7.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥95.1bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥77.1bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥71.6bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥65.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥63.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥16.3bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥7.2bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥78.8bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥69.9bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥64.6bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥61.8bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥60.1bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥10.7bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥19.2bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥141.8 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.22 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.97 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.48 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.45 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥141.41 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.88 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.79 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥54.37 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.33 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥919.68 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥817.09 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥746.98 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥710.8 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥690.85 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 82.5% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.3% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.3% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.3% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 94,259,400 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,060 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,004 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 906 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 869 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 850 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥1.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥559m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥57.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥5.5bn |
| Dental Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥3.4bn |
| Dental Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.9bn |
| Dental Productsreportable segment | employees | at 2023-12-31 | 1278 pure |
| Dental Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥48.3bn |
| Dental Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥48.3bn |
| Dental Productsreportable segment | segment assets | at 2023-12-31 | ¥70.1bn |
| Dental Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥16.7bn |
| Industrial Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥641m |
| Industrial Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥400m |
| Industrial Productsreportable segment | employees | at 2023-12-31 | 243 pure |
| Industrial Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥7.6bn |
| Industrial Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥7.6bn |
| Industrial Productsreportable segment | segment assets | at 2023-12-31 | ¥9.9bn |
| Industrial Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Surgical Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥616m |
| Surgical Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥96m |
| Surgical Productsreportable segment | employees | at 2023-12-31 | 139 pure |
| Surgical Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥3.8bn |
| Surgical Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥3.8bn |
| Surgical Productsreportable segment | segment assets | at 2023-12-31 | ¥3.6bn |
| Surgical Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.9bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥4.7bn |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥59.7bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥59.7bn |
| —segment total | segment assets | at 2023-12-31 | ¥83.6bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥19.8bn |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥1.0bn |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥490m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥61.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥4.9bn |
| Dental Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥2.2bn |
| Dental Productsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| Dental Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥40.9bn |
| Dental Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥40.9bn |
| Dental Productsreportable segment | segment assets | at 2022-12-31 | ¥28.8bn |
| Dental Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥17.0bn |
| Industrial Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥464m |
| Industrial Productsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥209m |
| Industrial Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥4.6bn |
| Industrial Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥4.6bn |
| Industrial Productsreportable segment | segment assets | at 2022-12-31 | ¥9.3bn |
| Industrial Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥1.7bn |
| Surgical Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥390m |
| Surgical Productsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥179m |
| Surgical Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥3.2bn |
| Surgical Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥3.2bn |
| Surgical Productsreportable segment | segment assets | at 2022-12-31 | ¥2.7bn |
| Surgical Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥3.0bn |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥48.7bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥48.7bn |
| —segment total | segment assets | at 2022-12-31 | ¥40.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥20.3bn |
| Dental Productsreportable segment | employees | at 2023-12-31 | 519 pure |
| Industrial Productsreportable segment | employees | at 2023-12-31 | 106 pure |
| Surgical Productsreportable segment | employees | at 2023-12-31 | 129 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,572
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital surplus | CurrentYearInstant | 3708703000 | JPY |
| Retained earnings | Prior1YearInstant | 93628490000 | JPY |
| Retained earnings | CurrentYearInstant | 112346913000 | JPY |
| Treasury stock | Prior1YearInstant | -9293944000 | JPY |
| Treasury stock | CurrentYearInstant | -11158651000 | JPY |
| Shareholders equity | Prior1YearInstant | 86382977000 | JPY |
| Shareholders equity | CurrentYearInstant | 105764913000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1403982000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 1607616000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 2950583000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 5487195000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 4354565000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 7094811000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 278685000 | JPY |
| Subscription rights to shares | CurrentYearInstant | 330967000 | JPY |
| Non controlling interests | Prior1YearInstant | 6427000 | JPY |
| Non controlling interests | CurrentYearInstant | 10303000 | JPY |
| Net assets | Prior1YearInstant | 91022656000 | JPY |
| Net assets | CurrentYearInstant | 113200996000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 102636471000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 140713091000 | JPY |
| Net sales | Prior1YearDuration | 48671452000 | JPY |
| Net sales | CurrentYearDuration | 59692369000 | JPY |
| Cost of sales | Prior1YearDuration | 17449753000 | JPY |
| Cost of sales | CurrentYearDuration | 23567952000 | JPY |
| Gross profit | Prior1YearDuration | 31221698000 | JPY |
| Gross profit | CurrentYearDuration | 36124416000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 15832469000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 21827871000 | JPY |
| Operating income | Prior1YearDuration | 15389229000 | JPY |
| Operating income | CurrentYearDuration | 14296545000 | JPY |
| Interest income noi | Prior1YearDuration | 102448000 | JPY |
| Interest income noi | CurrentYearDuration | 591000000 | JPY |
| Dividends income noi | Prior1YearDuration | 638780000 | JPY |
| Dividends income noi | CurrentYearDuration | 65498000 | JPY |
| Insurance premiums refunded cancellation noi | Prior1YearDuration | 226120000 | JPY |
| Insurance premiums refunded cancellation noi | CurrentYearDuration | 11285000 | JPY |
| Subsidy income noi | Prior1YearDuration | 35927000 | JPY |
| Subsidy income noi | CurrentYearDuration | 60225000 | JPY |
| Equity in earnings of affiliates noi | Prior1YearDuration | 812454000 | JPY |
| Equity in earnings of affiliates noi | CurrentYearDuration | － | JPY |
| Foreign exchange gains noi | Prior1YearDuration | 610939000 | JPY |
| Foreign exchange gains noi | CurrentYearDuration | 2088030000 | JPY |
| Miscellaneous income noi | Prior1YearDuration | 202941000 | JPY |
| Miscellaneous income noi | CurrentYearDuration | 305122000 | JPY |
| Non operating income | Prior1YearDuration | 2629610000 | JPY |
| Non operating income | CurrentYearDuration | 3121162000 | JPY |
| Interest expenses noe | Prior1YearDuration | 2761000 | JPY |
| Interest expenses noe | CurrentYearDuration | 13268000 | JPY |
| Loss on investments in money held in trust noe | Prior1YearDuration | 282091000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |